EMAIL THIS PAGE TO A FRIEND

Journal of autoimmunity

The Hsp60 peptide p277 enhances anti-CD3 mediated diabetes remission in non-obese diabetic mice.


PMID 25772283

Abstract

Type 1 diabetes (T1D) is characterized by the immune-mediated destruction of pancreatic beta cells leading to inadequate glycemic control. Trials with immunomodulatory monotherapies have shown that the disease course can in principle be altered. The observed preservation of endogenous insulin secretion however is typically transient and chronic treatment is often associated with significant side effects. Here we combined anti-CD3 with the Hsp60 peptide p277, two drugs that have been evaluated in Phase 3 trials, to test for enhanced efficacy. Female NOD mice with recent onset diabetes were given 5xa0μg anti-CD3 i.v., on three consecutive days in combination with 100xa0μg of p277 peptide in IFA s.c., once weekly for four weeks. Anti-CD3 alone restored normoglycemia in 44% of the mice while combination therapy with anti-CD3 and p277 induced stable remission in 83% of mice. The observed increase in protection occurred only in part through TLR2 signaling and was characterized by increased Treg numbers and decreased insulitis. These results have important implications for the design of combination therapies for the treatment of T1D.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

GW22787 Anti-TLR2 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
PRS3135
Anti-TLR2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
WH0007097M7
Monoclonal Anti-TLR2 antibody produced in mouse, clone 1E7, purified immunoglobulin, buffered aqueous solution
SAB1404474
Monoclonal Anti-TLR2 antibody produced in mouse, clone 2G9, purified immunoglobulin, buffered aqueous solution
SAB1409745
Monoclonal Anti-TLR2 antibody produced in mouse, clone 2A3, purified immunoglobulin, buffered aqueous solution
SAB1409746 Monoclonal Anti-TLR2 antibody produced in mouse, clone 2D2, purified immunoglobulin, buffered aqueous solution
SAB1409747 Monoclonal Anti-TLR2 antibody produced in mouse, clone 3F10, purified immunoglobulin, buffered aqueous solution
SAB1409748 Monoclonal Anti-TLR2 antibody produced in mouse, clone 1E3, purified immunoglobulin, buffered aqueous solution
SAB1409749 Monoclonal Anti-TLR2 antibody produced in mouse, clone 4D6, purified immunoglobulin, buffered aqueous solution
SAB1409750 Monoclonal Anti-TLR2 antibody produced in mouse, clone 4G9, purified immunoglobulin, buffered aqueous solution
SAB1409751 Monoclonal Anti-TLR2 antibody produced in mouse, clone 1C6, purified immunoglobulin, buffered aqueous solution
SAB1409752 Monoclonal Anti-TLR2 antibody produced in mouse, clone 1B10, purified immunoglobulin, buffered aqueous solution
SAB1409753 Monoclonal Anti-TLR2 antibody produced in mouse, clone 4C4, purified immunoglobulin, buffered aqueous solution
SAB1409754 Monoclonal Anti-TLR2 antibody produced in mouse, clone 3H8, purified immunoglobulin, buffered aqueous solution
SAB1409755 Monoclonal Anti-TLR2 antibody produced in mouse, clone 4H6, purified immunoglobulin, buffered aqueous solution